July 30, 2014 5:10 AM ET

Pharmaceuticals

Company Overview of Celecure AS

Company Overview

Celecure AS engages in the drug discovery and development of anticancer drugs. Its pipeline products include SB101, an angiogenesis inhibitor; CC0101, a tumor cell specific growth inhibitor; and Entrybodies, which are antibodies blocking intracellular proteins. The company was founded in 2002 and is based in Tallinn, Estonia.

Akadeemia tee 15

Tallinn,  12618

Estonia

Founded in 2002

Phone:

372 6 204 350

Key Executives for Celecure AS

Chairman and Chief Executive Officer
Head of Laboratories
Business Development Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Nycomed SEFA AS Europe
GlaxoSmithKline Eesti OU Europe
TBD-Biodiscovery Europe
Tallinna Farmaatsiatehase AS Europe
Bristol-Myers Squibb Eesti AS Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Celecure AS, please visit www.celecure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.